Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke

This study is a multicentre, randomized, blinded-endpoint trial that aims to evaluate the efficacy and safety of human urinary kallidinogenase combined with reteplase intravenous thrombolysis in the treatment of acute ischemic stroke

Participants needed: 220
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: China-Japan Union HospitalUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Meet the diagnostic criteria of the Chinese Guidelines for the Diagnosis and Tre... [+6]

Preoperative non-contrast head CT shows Alberta Stroke Program Early CT Score (A... [+16]

Read more
Status: Recruiting

Clinical Study on the Treatment of Rhinitis Sicca With Sodium Hyaluronate Adjustable Nasal Irrigator

To observe the therapeutic effect of sodium hyaluronate adjustable nasal irrigator on various types of rhinitis sicca and compare it with the therapeutic effect of the commonly used physiological seawater nasal spray in clinical practice.

Participants needed: 200
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: China-Japan Union HospitalUpdated: Dec 29, 2025Locations: 1
Eligibility criteria

Symptoms: Dry nose sensation, little and thick nasal discharge, nosebleeds, itch...

Those with dry rhinitis and chronic inflammation of the lower respiratory tract. [+6]

Read more
Status: Not yet recruiting

A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis Symptoms

Through prospective exploration of the efficacy of intranasal corticosteroids (INCS) combined with intranasal antihistamines (INAH) and INCS combined with oral antihistamines (OAH) in treating moderate to severe allergic rhinitis symptoms, this study aims to provide evidence-based medical evidence for the standardized treatment of patients with moderate to severe allergic rhinitis accompanied by typical nasal and ocular symptoms.

Participants needed: 50
Trial details
Phase: Phase 4Age: 12-75Biological sex: AllType: InterventionalSponsor: China-Japan Union HospitalUpdated: Dec 19, 2025
Eligibility criteria

Age range: 12-75 years old, both male and female are welcome; [+3]

Patients who are allergic to other excipients such as azelastine hydrochloride,... [+8]

Read more